Source: Daily News Egypt

Reliance Life Sciences: EIPICO, Reliance Life Science sign agreement to produce biologic drugs

EIPICO produces 18% of antibiotics available in Egyptian market The post EIPICO, Reliance Life Science sign agreement to produce biologic drugs appeared first on Daily News Egypt.

Read full article »
Reliance Life Sciences's Competitors | Reliance Life Sciences's News | Reliance Life Sciences's Financials
Stay up-to-date with the latest news on Reliance Life Sciences
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
K.V. Subramaniam's photo - President & CEO of Reliance Life Sciences

President & CEO

K.V. Subramaniam

CEO Approval Rating

67/100

Read more
Stay up-to-date with the latest news on Reliance Life Sciences